000 | 01884 a2200529 4500 | ||
---|---|---|---|
005 | 20250513194136.0 | ||
264 | 0 | _c19991210 | |
008 | 199912s 0 0 eng d | ||
022 | _a0027-8424 | ||
024 | 7 |
_a10.1073/pnas.96.22.12798 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDorn, G W | |
245 | 0 | 0 |
_aSustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. _h[electronic resource] |
260 |
_bProceedings of the National Academy of Sciences of the United States of America _cOct 1999 |
||
300 |
_a12798-803 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAmino Acid Sequence |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBiological Transport |
650 | 0 | 4 |
_aCardiotonic Agents _xchemical synthesis |
650 | 0 | 4 |
_aCell Death _xdrug effects |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aIsoenzymes _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 |
_aMyocardial Ischemia _xprevention & control |
650 | 0 | 4 |
_aOligopeptides _xchemical synthesis |
650 | 0 | 4 |
_aProtein Kinase C _xmetabolism |
650 | 0 | 4 | _aProtein Kinase C-epsilon |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aReceptors for Activated C Kinase |
650 | 0 | 4 |
_aReceptors, Cell Surface _xtherapeutic use |
700 | 1 | _aSouroujon, M C | |
700 | 1 | _aLiron, T | |
700 | 1 | _aChen, C H | |
700 | 1 | _aGray, M O | |
700 | 1 | _aZhou, H Z | |
700 | 1 | _aCsukai, M | |
700 | 1 | _aWu, G | |
700 | 1 | _aLorenz, J N | |
700 | 1 | _aMochly-Rosen, D | |
773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 96 _gno. 22 _gp. 12798-803 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.96.22.12798 _zAvailable from publisher's website |
999 |
_c10492901 _d10492901 |